Listen "258: Pharma vs. PBMs, Sarepta at the FDA, & a bold idea gone awry"
Episode Synopsis
We discuss a Senate hearing that put major pharma CEOs in the same room with the middlemen they love to blame for rising drug prices, with mixed results. We also explain what is a massive week for Sarepta Therapeutics, the FDA, and the future of gene therapies for rare diseases, plus the latest news in the life sciences.
More episodes of the podcast The Readout Loud
382: Biotech's year in review
18/12/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.